Biologicals

Acellular pertussis vaccine

Pertussis, acellular component of monovalent or combined vaccines

Title: Guidelines for the production and control of the acellular pertussis component of monovalent or combined vaccines; Adopted 1996, TRS no 878, Annex 2

UPCOMING EVENTS


  • WHO Informal Consultation on Amendment for Similar Biotherapeutic products of monoclonal antibodies, WCC, Geneva, Switzerland, 27–28 April 2015
  • WHO Informal Consultation on Regulatory risk assessment for biotherapeutic products, WCC, Geneva, Switzerland, 29–30 April 2015

Contacts


Technologies Standards and Norms (TSN)
Essential Medicines and Health Products (EMP)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971